8326 - 8350 of 8715 Results
Title
Year
-
OPENTitle: Environmental Risk Factors for Progressive Supranuclear PalsyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 103End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20173Best OA location URL: https://doi.org/10.14802/jmd.20173Citation Count: 23
-
OPENTitle: Quantification of blood–brain barrier transport and neuronal toxicity of unlabelled multiwalled carbon nanotubes as a function of surface chargeJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 45Start Page: 22054End Page: 22069Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1039/c9nr02866hCitation Count: 42
-
OPENTitle: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the artJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01144-2Best OA location URL: https://doi.org/10.1038/s41746-024-01144-2Citation Count: 14
-
RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
RESTRICTEDTitle: High-Throughput Extracellular Vesicle Isolation Using Plate-Based Size Exclusion Chromatography and AutomationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 16Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/jacs.4c17948Citation Count: 0
-
RESTRICTEDTitle: Machine learning methods for optimal prediction of motor outcome in Parkinson’s diseaseJournal Name: Physica MedicaPublisher: Elsevier BVVol: 69Issue #:Start Page: 233End Page: 240Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmp.2019.12.022Citation Count: 41
-
OPENTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Best OA location URL: https://scholarsphere.psu.edu/resources/29554bfc-5d79-4aa6-b1c5-e9441fea8e4aCitation Count: 8
-
OPENTitle: Alternating Magnetic Field-Promoted Nanoparticle Mixing: The On-Chip Immunocapture of Serum Neuronal Exosomes for Parkinson’s Disease DiagnosticsJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 95Issue #: 20Start Page: 7906End Page: 7913Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.3c00357Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.3c00357Citation Count: 27
-
OPENTitle: Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCANJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100331End Page: 100331Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100331Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100331Citation Count: 1
-
OPENTitle: Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 854End Page: 865Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29349Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29349Citation Count: 14
-
OPENTitle: Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicityJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 3Issue #: 1Start Page: 96End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1cb00103eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2022/cb/d1cb00103eCitation Count: 11
-
OPENTitle: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformationsJournal Name: Protein SciencePublisher: WileyVol: 31Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4360Citation Count: 9
-
RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 42
-
RESTRICTEDTitle: Lasmiditan ameliorates cortico-hippocampal pathology and improves cognition in aging parkinsonian miceJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 395Issue #:Start Page: 115502End Page: 115502Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115502Citation Count: 0
-
OPENTitle: Thermodynamic characterization of amyloid polymorphism by microfluidic transient incomplete separationJournal Name: Chemical SciencePublisher: Royal Society of Chemistry (RSC)Vol: 15Issue #: 7Start Page: 2528End Page: 2544Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d3sc05371gBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2024/sc/d3sc05371gCitation Count: 13
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 22
-
OPENTitle: IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://doi.org/10.1002/prp2.65Citation Count: 43
-
OPENTitle: The Exon-Based Transcriptomic Analysis of Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 15Issue #: 3Start Page: 440End Page: 440Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom15030440Best OA location URL: https://doi.org/10.3390/biom15030440Citation Count: 0
-
OPENTitle: Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In SituJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0165964End Page: e0165964Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0165964Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0165964&type=printableCitation Count: 63
-
OPENTitle: Impact ofGBA1variants on long-term clinical progression and mortality in incident Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 7Start Page: 695End Page: 702Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2020-322857Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/7/695.full.pdfCitation Count: 80
-
OPENTitle: Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S MutationJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 12Issue #: 1Start Page: 29End Page: 41Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.11.021Best OA location URL: http://www.cell.com/article/S2213671118304909/pdfCitation Count: 72
-
OPENTitle: Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae146Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae146/57311805/fcae146.pdfCitation Count: 2
-
OPENTitle: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 3Start Page: 312End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2773698/jamaneurology_simuni_2020_oi_200091_1614894403.37383.pdfCitation Count: 111
-
OPENTitle: Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 4Start Page: e0266405End Page: e0266405Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0266405Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0266405&type=printableCitation Count: 5
-
RESTRICTEDTitle: Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1601End Page: 1608Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27362Citation Count: 241